Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;89:1974-1981

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X. L.
Right arrow Articles by Wilcken, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X. L.
Right arrow Articles by Wilcken, D. E.

Circulation, Vol 89, 1974-1981, Copyright © 1994 by American Heart Association


ARTICLES

Determinants of severity of coronary artery disease in Australian men and women

XL Wang, C Tam, RM McCredie and DE Wilcken
Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, Australia.

BACKGROUND: Factors predicting the occurrence of premature coronary artery disease (CAD) may not be quantitatively the same as those predicting CAD severity, particularly in women, in whom there have been few studies. METHODS AND RESULTS: To determine factors predictive of severity of CAD and of angina pectoris, we documented atherogenic variables and the extent of CAD at angiography in 594 consecutively studied men and women aged 65 years or less. Severity was assessed from the number of involved major coronary arteries with significant (> 50%) luminal obstructions and from a coronary disease severity score. We related severity to quantitative and categorical atherogenic variables and assessed severity of angina (no angina, stable angina, or unstable angina) at the time of study in the same way. There were eight variables independently predictive of severity: in descending order of relative importance, male gender, diabetes, smoking dose, ratio of total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C), lipoprotein(a) [Lp(a)], age, positive family history, and hypertension. These correctly classified 43.3% of patients into no-, one-, two-, and three-vessel disease categories and accounted for 25.8% of variance of severity. Among 246 patients not taking lipid-lowering or beta-blocking drugs, these variables (in slightly different order) correctly classified 49.2% of patients and accounted for 36% of the variance. Among men (n = 427), seven significant variables correctly classified 39.3% of patients compared with 54.5% in women (n = 167). For those not taking the above drugs, these proportions were 49.4% and 65.4%, respectively. Among the quantitative variables, total smoking dose was the most predictive independent variable irrespective of current or ex- smoking habit and was more predictive in women than in men; of the lipid variables, high TC/HDL-C (or low HDL-C) and high Lp(a) were consistently highly predictive for all patients and in the subgroup analyses. Patients with unstable angina had higher coronary severity scores and Lp(a) levels and were more likely to have diabetes, hypertension, or a positive family history. CONCLUSIONS: We conclude that the quantitative variables most relevant to severity of premature CAD and to its prevention in Australian men and women are total amount of lifetime smoking, TC/HDL-C (or HDL-C), and Lp(a) and that patients with unstable versus stable angina usually have more severe disease and higher Lp(a).


This article has been cited by other articles:


Home page
CirculationHome page
P. R. Kamstrup, M. Benn, A. Tybjaerg-Hansen, and B. G. Nordestgaard
Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study
Circulation, January 15, 2008; 117(2): 176 - 184.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. A. Ambrose and R. S. Barua
The pathophysiology of cigarette smoking and cardiovascular disease: An update
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1731 - 1737.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Frohlich and M. Dobiasova
Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography
Clin. Chem., November 1, 2003; 49(11): 1873 - 1880.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D.E.L. Wilcken
Homocysteine, smoking and vascular disease
Eur. Heart J., October 2, 2002; 23(20): 1559 - 1560.
[Full Text] [PDF]


Home page
Hum ReprodHome page
G. Ricci, G. Tamaro, R. Simeone, E. Giolo, G. Nucera, F. De Seta, and S. Guaschino
Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH
Hum. Reprod., March 1, 2001; 16(3): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.E Roeters van Lennep, A.H Zwinderman, H.W.O Roeters van Lennep, H.E Westerveld, H.W.M Plokker, A.A Voors, A.V.G Bruschke, and E.E van der Wall
Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997. No evidence for the Yentl syndrome
Eur. Heart J., June 1, 2000; 21(11): 911 - 918.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. C. Mahaney, S. A. Czerwinski, T. Adachi, D. E. L. Wilcken, and X. L. Wang
Plasma Levels of Extracellular Superoxide Dismutase in an Australian Population : Genetic Contribution to Normal Variation and Correlations With Plasma Nitric Oxide and Apolipoprotein A-I Levels
Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 683 - 688.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Margaglione, G. Cappucci, D. Colaizzo, G. Vecchione, E. Grandone, and G. Di Minno
C-Reactive Protein in Offspring Is Associated With the Occurrence of Myocardial Infarction in First-Degree Relatives
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 198 - 203.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, G. J. King, T. L. Bair, S. P. Elmer, J. B. Muhlestein, J. Habashi, L. Mixson, and J. F. Carlquist
Association of lipoprotein lipase gene polymorphisms with coronary artery disease
J. Am. Coll. Cardiol., March 15, 1999; 33(4): 1013 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Schmermund, K. R. Bailey, J. A. Rumberger, J. E. Reed, P. F. Sheedy II, and R. S. Schwartz
An algorithm for noninvasive identification of angiographic three-vessel and/or left main coronary artery disease in symptomatic patients on the basis of cardiac risk and electron-beam computed tomographic calcium scores
J. Am. Coll. Cardiol., February 1, 1999; 33(2): 444 - 452.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Zureik, P.-J. Touboul, C. Bonithon-Kopp, D. Courbon, I. Ruelland, and P. Ducimetiere
Differential Association of Common Carotid Intima-Media Thickness and Carotid Atherosclerotic Plaques With Parental History of Premature Death From Coronary Heart Disease : The EVA Study
Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 366 - 371.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. L. Wang, T. Adachi, A. S. Sim, and D. E. L. Wilcken
Plasma Extracellular Superoxide Dismutase Levels in an Australian Population With Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1915 - 1921.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. Su, H. Campos, H. Judge, B. W. Walsh, and F. M. Sacks
Metabolism of Apo(a) and ApoB100 of Lipoprotein(a) in Women: Effect of Postmenopausal Estrogen Replacement
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3267 - 3276.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Hibi, T. Ishigami, K. Tamura, S. Mizushima, N. Nyui, T. Fujita, H. Ochiai, M. Kosuge, Y. Watanabe, Y. Yoshii, et al.
Endothelial Nitric Oxide Synthase Gene Polymorphism and Acute Myocardial Infarction
Hypertension, September 1, 1998; 32(3): 521 - 526.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Margaglione, G. Cappucci, D. Colaizzo, N. Giuliani, G. Vecchione, E. Grandone, O. Pennelli, and G. Di Minno
The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 152 - 156.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Tkac, B. P. Kimball, G. Lewis, K. Uffelman, and G. Steiner
The Severity of Coronary Atherosclerosis in Type 2 Diabetes Mellitus Is Related to the Number of Circulating Triglyceride-Rich Lipoprotein Particles
Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3633 - 3638.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Clarkson, D. S. Celermajer, A. J. Powe, A. E. Donald, R. M. A. Henry, and J. E. Deanfield
Endothelium-Dependent Dilatation Is Impaired in Young Healthy Subjects With a Family History of Premature Coronary Disease
Circulation, November 18, 1997; 96(10): 3378 - 3383.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams
Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2783 - 2792.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
X.L Wang, J Wang, and D.E.L Wilcken
Interactive effect of the p53 gene and cigarette smoking on coronary artery disease
Cardiovasc Res, August 1, 1997; 35(2): 250 - 255.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X.L. Wang, J. Wang, R.M. McCredie, and D.E.L. Wilcken
Polymorphisms of Factor V, Factor VII, and Fibrinogen Genes: Relevance to Severity of Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., February 1, 1997; 17(2): 246 - 251.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. E.L. Wilcken, X. L. Wang, A. S. Sim, and R. M. McCredie
Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C677T Mutation
Arterioscler. Thromb. Vasc. Biol., July 1, 1996; 16(7): 878 - 882.
[Abstract] [Full Text]


Home page
NEJMHome page
P. S. Douglas and G. S. Ginsburg
The Evaluation of Chest Pain in Women
N. Engl. J. Med., May 16, 1996; 334(20): 1311 - 1315.
[Full Text] [PDF]


Home page
CirculationHome page
X.L. Wang, R.M. McCredie, and D.E.L. Wilcken
Common DNA Polymorphisms at the Lipoprotein Lipase Gene : Association With Severity of Coronary Artery Disease and Diabetes
Circulation, April 1, 1996; 93(7): 1339 - 1345.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
K.M.A. Hussain, L. Gould, B. Sosler, T. Bharathan, and C.V.R. Reddy
Clinical Science Review: Current Aspects of Thrombolytic Therapy in Women with Acute Myocardial Infarction
Angiology, January 1, 1996; 47(1): 23 - 33.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X.L. Wang, R.M. McCredie, and D.E.L. Wilcken
Genotype Distribution of Angiotensin-Converting Enzyme Polymorphism in Australian Healthy and Coronary Populations and Relevance to Myocardial Infarction and Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 115 - 119.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. L. Wang, R. M. McCredie, and D. E. L. Wilcken
Polymorphisms of the Apolipoprotein E Gene and Severity of Coronary Artery Disease Defined by Angiography
Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1030 - 1034.
[Abstract] [Full Text]


Home page
CirculationHome page
R. F. Badenhop, X. L. Wang, and D. E.L. Wilcken
Angiotensin-Converting Enzyme Genotype in Children and Coronary Events in Their Grandparents
Circulation, March 15, 1995; 91(6): 1655 - 1658.
[Abstract] [Full Text]


Home page
NEJMHome page
G. N. Levine, J. F. Keaney, and J. A. Vita
Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms
N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521.
[Full Text] [PDF]